BCHE and Parkinson disease: For example, remifentanil requirement for the inhibition of responses to tracheal intubation and surgical incision are markedly reduced in PD patients.[5] As a reversal agent for neuromuscular blockade, there are concerns with cholinesterase inhibitors given the theoretical possibility that they could worsen PD-related symptoms, particularly those involving movement.